What are the recommended medications for managing constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Medications for Constipation

Start with polyethylene glycol (PEG) 17g daily as first-line pharmacological therapy for chronic constipation, as it has strong evidence, proven durability over 6 months, and costs only $10-45 monthly. 1

Algorithmic Approach to Medication Selection

First-Line: Over-the-Counter Osmotic Laxatives

Polyethylene glycol (PEG) is the strongest recommendation among all agents 1:

  • Dose: 17g daily, titrate based on response
  • Mechanism: Osmotic laxative that traps water in intestine
  • Cost: $10-45/month
  • Side effects: Bloating, abdominal discomfort, cramping
  • Key advantage: Durable response demonstrated over 6 months

Alternative osmotic laxatives (conditional recommendations) 1:

  • Lactulose 15g daily (<$50/month) - only osmotic agent studied in pregnancy; expect bloating/flatulence
  • Magnesium oxide 400-500mg daily (<$50/month) - avoid in renal insufficiency and pregnancy

Second-Line: Stimulant Laxatives (Short-term/Rescue Only)

Sodium picosulfate receives a strong recommendation, while bisacodyl and senna are conditional 1:

  • Bisacodyl 5mg daily (max 10mg) or Senna 8.6-17.2mg daily
  • Cost: <$50/month
  • Critical caveat: Recommended for short-term use or rescue therapy only - prolonged use causes diarrhea and electrolyte imbalance; long-term safety unknown 1

Third-Line: Prescription Secretagogues (Strong Recommendations)

If OTC options fail, escalate to prescription agents with strong evidence 1:

Linaclotide (intestinal secretagogue):

  • Dose: 72-145μg daily, max 290μg daily
  • Cost: $523/month
  • Advantage: May benefit abdominal pain; also approved for IBS-C
  • Risk: Diarrhea in subset of patients

Plecanatide (intestinal secretagogue):

  • Dose: 3mg daily
  • Cost: $526/month
  • Similar profile to linaclotide

Prucalopride (5-HT4 agonist):

  • Dose: 1-2mg daily
  • Cost: $563/month
  • Advantage: May benefit abdominal pain
  • Risk: Headaches and diarrhea

Alternative Prescription Option (Conditional Recommendation)

Lubiprostone (chloride channel activator):

  • Dose: 24μg twice daily
  • Cost: $374/month
  • Advantage: May benefit abdominal pain
  • Note: Received only conditional recommendation despite being prescription 1

Key Clinical Considerations

Fiber supplementation (14g/1000 kcal intake) received only a conditional recommendation 1 - ensure adequate hydration as bloating/discomfort are common. This is notably weaker evidence than PEG.

Cost-effectiveness hierarchy: The 2023 AGA-ACG guidelines 1 clearly favor starting with inexpensive OTC options (PEG, stimulants <$50/month) before escalating to prescription agents ($374-563/month), unless specific symptoms like abdominal pain warrant earlier use of secretagogues.

Common pitfall: Clinicians often jump to prescription agents without adequate trial of PEG, which has the strongest evidence base and is dramatically less expensive. The guidelines explicitly made strong recommendations for PEG, sodium picosulfate, linaclotide, plecanatide, and prucalopride, while fiber, lactulose, senna, magnesium oxide, and lubiprostone received only conditional recommendations 1.

Pregnancy consideration: Lactulose is the only osmotic agent studied in pregnancy 1. Avoid magnesium oxide in pregnancy and renal insufficiency.

Dose titration: All agents should be titrated per symptom response and side effects - there are no clear maximum doses for most osmotic laxatives 1.

References

Related Questions

What is the appropriate evaluation and management for a 15-year-old with infrequent bowel movements (approximately one stool every four days)?
What is the appropriate management of constipation in an infant younger than 6 months?
What is the appropriate management for a 5‑month‑old infant who has not passed a bowel movement for three days?
What is the recommended approach to managing constipation in a healthy 1‑month‑old infant?
What is the most effective osmotic laxative for adult constipation?
Can Crohn's disease lead to bronchiectasis?
Can psychological stress cause an elevated C-reactive protein level of 1.07 mg/L?
For an 82‑year‑old male with diabetes, hyperlipidemia, prior prostate cancer, presenting with fatigue, hyperglycemia, elevated BUN, reduced eGFR, elevated ALT, borderline high triglycerides, low HDL, mild anemia, and high vitamin B12, what further laboratory tests and treatment interventions are indicated?
Can a physician prescribe a medication to enforce abstinence from alcohol for a patient?
In an 82‑year‑old man with diabetes, chronic kidney disease, elevated liver enzymes, dyslipidemia, mild anemia, and high vitamin B12, do thyroid function test results showing thyroid‑stimulating hormone 2.4 mIU/L and free thyroxine 1.27 ng/dL indicate hypothyroidism as the cause of his fatigue, and should thyroid‑specific therapy be started?
How should pain on palpation of the right adnexal region be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.